Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisoprolol for Heart Rate Reduction in Chinese Chronic Heart Failure
NCT03026088Phase 4Terminated
- Sponsor
- Merck KGaA
- Start
- Mar 2017
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bisoprolol in chronic heart failure (CHF), sponsored by Merck KGaA. Started Mar 2017; status: terminated.
02
Drugs
bisoprolol
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT03026088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03026088.